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ABSTRACT: The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has
been an attractive target for treating mood and anxiety disorders such as
schizophrenia. We have developed binary classification quantitative structure−
activity relationship (QSAR) models of 5-HT1A receptor binding activity using
data retrieved from the PDSP Ki database. The prediction accuracy of these
models was estimated by external 5-fold cross-validation as well as using an
additional validation set comprising 66 structurally distinct compounds from
the World of Molecular Bioactivity database. These validated models were
then used to mine three major types of chemical screening libraries, i.e., drug-
like libraries, GPCR targeted libraries, and diversity libraries, to identify novel
computational hits. The five best hits from each class of libraries were chosen
for further experimental testing in radioligand binding assays, and nine of the
15 hits were confirmed to be active experimentally with binding affinity better
than 10 μM. The most active compound, Lysergol, from the diversity library
showed very high binding affinity (Ki) of 2.3 nM against 5-HT1A receptor. The novel 5-HT1A actives identified with the QSAR-
based virtual screening approach could be potentially developed as novel anxiolytics or potential antischizophrenic drugs.
■ INTRODUCTION
The 5-HT1A receptor is one the most abundant subtypes of the
5-HT receptor family; it is highly enriched in the raphe nucleus,
cerebral cortex, hippocampus, septum, and amygdale. Because
of its presence in the brain regions whose functions are heavily
involved in mood and anxiety disorders, the 5-HT1A receptor
has been actively explored as a target for antipsychotic,
anxiolytic and antidepressant drug discovery. Several 5-HT1A
receptor agonists such as buspirone and tandospirone are
medications approved to treat anxiety and depression. Some of
the atypical antipsychotic drugs, such as aripiprazole, clozapine,
and olanzapine, are also partial 5-HT1A receptor agonists and
are sometimes used in low doses in combination with standard
antidepressants to achieve faster symptom relief and greater
overall efficacy.1−3 Furthermore, 5-HT1A receptors have been
actively studied as potential drug targets for treating the
cognitive deficits in schizophrenia:4 the activation of the 5-
HT1A receptor has been linked to the increased dopamine
release, which could improve certain symptoms of schizo-
phrenia.5,6 Besides being traditionally explored as targets for
psychiatric disorders, 5-HT1A receptors have recently received
considerable attention as targets to develop treatments for
neurodegenerative diseases.7 Recent discoveries have shown
that the modulation of 5-HT1A receptor may present a novel
mechanism for treating the Alzheimer’s disease or help relieve
the symptoms of Parkinson’s disease.8
Although several drugs are available on market that acting via
a 5-HT1A receptor-mediated mechanism, only a few were
originally developed to selectively target 5-HT1A receptors. In
addition, current 5-HT1A modulators exhibit various side effects
or even some severe side effects,9 preventing their widespread
clinical use. These side effects could be due to potent off-target
actions.10,11 Moreover, some patients have been reported to be
nonresponders or poor-responders to current medications.12
Thus, there is still a need for developing novel 5-HT1A receptor
modulators.
Virtual screening (VS) is a common and efficient approach
for the discovery of new lead compounds.13 Structure-based VS
has been the most popular approach to identify putative
receptor actives in chemical libraries,14 but in recent years,
ligand-based cheminformatics approaches have been used
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widely in VS applications15 as well. In the case of 5-HT1A
receptors, when the experimental structure of the receptor is
unknown, ligand-based approaches can be explored for VS. Our
group has been investigating the use of quantitative structure
activity relationships (QSAR) models as effective VS tools, and
several successful applications have been reported.15−17 The
QSAR approach explores existing chemical databases with
biologically activities to establish statistically significant and
externally predictive models that allow one to predict biological
activity of untested compounds from their chemical structures.
Once a QSAR model has been developed, it can be used to
search libraries of chemical structures with the aim of finding
new, structurally different hit(s) with the desired biological
activity.18 Indeed, the size and diversity of chemical libraries
available for both virtual and experimental screening have been
growing rapidly in recent years, providing growing oppor-
tunities to use VS methods to identify novel hits among
available chemicals.
In this paper, we report on the development of rigorously
validated QSAR models of the 5-HT1A receptor binders using
previously reported bioactivity data for the receptor ligands. We
employ these models for virtual screening to arrive at a small
number of 15 prioritized computational hits that have been
subject to experimental validation. We show that 9 of these 15
hits show appreciable binding affinity ranging between 10 μM
and 2.3 nM. This study confirms that QSAR-based virtual
screening is an effective tool to discover novel bioactive
compounds that can be further pursued as novel antipsychotics.
■ METHODS
Data Sets for Model Building and Validation. Data
Sets for QSAR Model Building. The data for 5-HT1A activity
were retrieved from the National Institute of Mental Health
(NIMH) Psychoactive Drug Screening Program (PDSP) Ki
database.19 In this study, we used 10 μM as the cutoff value to
define actives versus inactives, and we only retrieved the
experimental radioligand binding data with cloned human cell
lines using the ligand [3H]-8-OH-DPAT. By submitting such
queries, 180 unique compounds were designated as 5-HT1A
actives with binding affinities ranging from 0.115 nM to 8.41
μM. We also retrieved 78 inactives, which were shown
experimentally to have no binding affinity to the 5-HT1A
receptor at 10 μM concentration.
Data Set for Independent External Validation. An
additional 66 putative 5-HT1A actives were extracted from the
World of Molecular Bioactivity (WOMBAT) database.20 This
commercial database is a collection of chemical annotations
published in top medicinal chemistry journals; therefore, the
binding data therein are considered as highly reliable.
Compounds extracted from WOMBAT were regarded as 5-
HT1A actives when they satisfied all of the following criteria:
(1) compounds were tested on cloned human species cell lines;
(2) [3H]-8-OH-DPAT was used as hot ligand; (3) their binding
affinities were higher than 10 μM. Notably, all 66 compounds
were different structurally from compounds in the modeling
set.
Data Set Curation. Prior to QSAR model development,
chemical structures were curated following the guidelines we
published earlier.21 First, all molecules were cleaned using the
“Wash Molecules” module in Molecular Operating Environ-
ment (MOE,22 version 2009.10). Second, the routine Stand-
ardizer was used for structure canonicalization and trans-
formation, JChem 5.2, 2009, ChemAxon (http://www.
chemaxon.com). Finally, duplicates were detected by the
analysis of the normalized molecular structures. For chemicals
extracted from the PDSP Ki database, 75 duplicate compounds
for 5-HT1A actives and 17 for inactives, i.e., different salts or
isomeric states, were detected. The functional data for
Figure 1. The workflow of QSAR model building, validation and virtual screening as applied to the 5-HT1A data set of 105 actives and 61 inactives
from PDSP.
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duplicates were verified to be identical, so in each case a single
example was removed. The curated subset of the 5-HT1A
ligands from PDSP included 166 unique organic compounds
(105 actives and 61 inactives). The chemical structures of these
compounds are available in the Supporting Information.
Libraries for Virtual Screening. Drug-Like Screening
Libraries. Drug-like libraries are collections of currently
marketed drugs or drug candidates in the approval process.
For our study, we used the World Drug Index (WDI) database
and the Prestwick Chemical Library (PCL) (http://www.
prestwickchemical.fr/). The WDI library is maintained by
Derwent Publications and our version contains 59 000
pharmacologically active compounds, including all marketed
drugs and those in the development. The PCL contains 1200
small molecules, all of which are marketed drugs. By design,
compounds in the PCL feature a high chemical and
pharmacological diversity as well as a high degree of
bioavailability and safety in human.
Targeted Screening Libraries. The 5-HT1A receptor belongs
to the large family of GPCRs; therefore, GPCR-targeted
libraries such as TimTec (http://www.timtec.net/) AntiTarg-G
library and ASINEX (http://www.asinex.com/) Synergy
GPCRs CNS library were used for virtual screening to identify
new putative 5-HT1A ligands. The TimTec AntiTarg-G library
is a plated screening set of 2300 molecules that contain
chemical scaffolds present in compounds reported in the
technical or patent literature to bind GPCRs. Similarly, the
ASINEX Synergy GPCRs CNS library is composed of 3233
compounds rich in GPCRs drug-like pharmacophore frag-
ments.
Diversity Screening Libraries. The diversity libraries were
also from TimTec and ASINEX, namely TimTec Diversity Set
10K and ASINEX Diverse Set-Platinum 5K. The TimTec
diversity screening set contains 10 000 samples selected from
the company’s stock of over 180 000 compounds as the most
structurally diverse and competitively priced collection. The
assorted set stands out as having a diverse selection of
singletons identified in the TimTec stock of readily available
compounds. In addition, it is also a compound collection that
complies with Lipinski’s Rule of Five. ASINEX Diversity Set-
Platinum 5K, which contains 5072 compounds, is an
assortment of all ASINEX libraries based on the compounds’
structural diversity. This set of compounds is claimed by
ASINEX to be a great starting point that requires a diverse
chemical collection.
Training, Test, and External Validation Sets Selection.
We have followed the rigorous QSAR modeling workflow for
model building, validation, and virtual screening (Figure 1)
developed in our laboratory.23 This workflow requires that an
external predictive power should be established for every QSAR
model. Thus, we have employed the external 5-fold cross-
validation protocol where the modeling set is randomly split
into five subsets of approximately equal size (20% of
compounds). Each time, one subset is used as an external
validation set, and the union of four other subsets is used as the
modeling set, i.e., each modeling set contains 80% of
compounds. Modeling sets were further partitioned into
multiple pairs of representative training and test sets of
different sizes using the Sphere Exclusion algorithm developed
in our laboratory,24,25 which ensures the closeness in chemical
spaces within the paired data sets.
Generation of 2D Molecular Descriptors. The
SMILES26 strings of each compound in the 5-HT1A data set
were converted to 2D chemical structures using the MOE
software package. The Dragon27 software (version 5.5) was
used to calculate a wide range of topological indices of
molecular structures. Dragon descriptors with zero values or
zero variance were excluded, whereas the remaining descriptors
were range-scaled within the interval of 0−1 prior to distance
calculations and model building because the absolute scales for
the variety of Dragon descriptors can differ by orders of
magnitude.28
QSAR Modeling Methods. k Nearest Neighbors (kNN)
Classification Method. The kNN classification QSAR
method28,29 is based on the idea that the class that a compound
belongs to can be predicted by the class membership of its
nearest neighbors (i.e., most similar compounds), taking into
account weighted similarities between the compound and its
nearest neighbors. Because our implementation of kNN
approach includes variable selection, the similarity is evaluated
using only a subset of all descriptors, which is optimized by a

























total are the number of actives and inactives
in the data set, and N1
corr and N2
corr are the number of known
actives correctly predicted as actives (true positives) and the
number of inactives correctly predicted as inactives (true
negatives), respectively. Unlike total accuracy, CCR inherently
took into account the imbalance in class membership of objects
in the data set, which was important because the 5HT1A data
set was imbalanced containing 105 actives and 61 inactives. The
accuracy of the models was characterized by the leave-one-out
cross-validation (LOO-CV) CCRtrain for the training sets and
predictive CCRtest for the test sets. Additional details of this
approach can be found elsewhere.28,31 Models with high
CCRtrain and CCRtest were used to predict compounds included
neither in the training nor in the test set as a matter of external
validation. Theoretically, any compound represented by the
corresponding chemical descriptors can be assigned to a class
(predicted class) using the classification kNN approach.
However, if the distances between the query compound and
all of its k nearest neighbors in the training set are higher than
some threshold, the query compound is considered as highly
dissimilar from all of the training set compounds, and the
prediction of its activity using the kNN approach is considered
unreasonable. Therefore, a similarity threshold (or model
applicability domain, AD) was introduced to avoid making
predictions for compounds that differ substantially from the
training set molecules.32 The distance threshold is defined as
follows:
σ= ̅ +D y nT (2)
Here, y ̅ is the average Euclidean distance between each
compound and its k nearest neighbors within the training set,
σ is its standard deviation of these distances, and n is an
arbitrary parameter called the n-cutoff to control the
significance level. Typically, we set n to 0.5, which places the
boundary for deciding whether a compound is within or outside
of the AD at one-half of the standard deviation from y.̅ It is
important to notice that increasing the value of n would
increase the number of compounds in the external set that are
considered within the AD but could decrease the accuracy of
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the prediction due to the inclusion of dissimilar nearest
neighbors.
Random Forest (RF) Classification Method. Random Forest
is a machine learning technique that consists of many decision
trees and outputs the consensus prediction from the individual
trees.33 In this study, the implementation of an RF34 algorithm
available in the R Project35 (Version 2.14.1) was used. In the
RF modeling procedure, N samples (modeling set compounds)
are randomly drawn with replacement from the original data
set. These samples were used to construct n training sets and to
build n trees. In these studies, n was equal to 500. Predictions
were made by averaging predicted activities over all trees in the
final forest.
Support Vector Machines (SVM) Classification Method.
The original version of SVM was developed by V. Vapnik36 and
the description of the SVM algorithm can be found in many
publications.37,38 Briefly, molecular descriptors are first mapped
onto a high dimensional feature space using various kernel
functions. Then, SVM finds a separating hyperplane with the
maximal margin in this high dimensional space to separate
compounds with different activities. Models built with SVM
allow for the prediction of the target property using a set of
descriptors solely calculated from the structure of a given
compound.
In this study, we used the WinSVM program developed in
our group (freely available for academic laboratories upon
request) implementing the open-source LIBSVM package.37
The WinSVM program provides users with a convenient
graphical interface to prepare input data, perform SVM
modeling, and select models for external evaluation. The
program also allows one to visualize molecular structures and
produce various plots, making the use of SVM easier and more
appropriate for QSAR modeling to obtain robust and predictive
models and apply them to virtual libraries.39
Robustness of QSAR Models. A Y-randomization test was
used to ensure the model robustness.40 This test includes
rebuilding the training set models using randomized activities
(Y-vector) of the training set and comparing the resulting
model statistics with that of the models built with original data.
It is expected that models built with randomized activities
should have significantly lower CCR values for both the
training and test sets. The one-tail hypothesis testing was
applied to confirm the robustness of QSAR models. In this
approach, two alternative hypotheses are formulated: (1) for
H0, h = μ; (2) for H1, h > μ, where μ is the average value of
CCRtrain for Y-randomization models and h is that for the actual
models. The null hypothesis (H0) states that the QSAR models
for the actual data set are not significantly better than random
models, whereas the H1 hypothesis assumes the opposite,
suggesting that the actual models are significantly better than
the random models. Hypothesis rejection is based on a
standard one-tail test, which involves the following three steps:
(1) determine the average value of CCRtrain (μ) and its
standard deviation (σ) for random models; (2) calculate the Z
score that corresponds to the average value of CCRtrain (h) for
the actual models using the following equation:
μ σ= −hZ ( )/ (3)
(3) Compare this Z score with the tabular critical values of Zc at
different levels of significance (α)60 to determine the level at
which H0 should be rejected. If the Z score is higher than
tabular values of Zc, one concludes that at the level of
significance that corresponds to that Zc, H0 should be rejected
while H1 should be accepted. The Y-randomization test was
applied to all data sets considered in this study, and the test was
repeated twice in each case.
Virtual Screening using Consensus Models. As
illustrated in the workflow of Figure 1, QSAR models that
passed both internal and external validation were employed for
virtual screening. A global applicability domain (calculated
using all descriptors) was applied first to filter out compounds
that were structurally highly different (beyond the AD
threshold calculated with n-cutoff = 0.5, cf. eq 2) from
compounds in the modeling set. All 105 known 5-HT1A actives
extracted from PDSP were used as probes in the chemical
similarity calculations. Then, all acceptable models obtained
with various machine learning techniques, kNN, RF, and SVM,
were applied in consensus to predict the class of compounds in
the external library that were found within the global
applicability domain. Furthermore, the results were accepted
only when the compound was found within the applicability
domains of more than 50% of all models used in consensus
prediction and the standard deviation of estimated means
across all models was small. During the consensus prediction of
kNN, we restricted ourselves to the most conservative AD for
each model using the n-cutoff = 0.5 in eq 2.
All the modeling and virtual screening calculations were
carried out at a 352-processor Beowulf Linux cluster of the ITS
Research Computing Division of the University of North
Carolina at Chapel Hill (UNCCH). The CPU nodes are
Intel Xeon IBM BladeCenter of Dual Intel Xeon 2.8 GHz, with
2.5GB RAM on each node. The cluster runs the Red Hat
Enterprise Linux 4.0 (32-bit) and the nodes communicate via a
Gigabit Ethernet network. The processing speed of QSAR-
based screening is ca. 100K compounds per minute, fairly high
compared to other methods. In addition, the data processing
speed was found to be able to scale linearly with the size of the
screening library.
Fingerprint Based Similarity Search. The chemical
similarity search was conducted with the MOE 2006.08
package using the standard protocol. The MACCS structural
keys were utilized with the Tanimoto Coefficient (Tc) as the
similarity metric. In the case that the hits from individual
searches were in duplicate, a special Scientific Vector Language
(SVL) script was employed to remove them by considering
both chemical topology and chirality.
Radioligand Binding Assays. The experimental tests were
performed by the National Institute of Mental Health PDSP
program (http://pdsp.med.unc.edu/indexR.html). The five
computational hits from Prestwick library were purchased
from Sigma-Aldrich, and the ten additional compounds were
purchased from TimTec LLC (cf. Certificate of Analysis in the
Supporting Information). Radioligands were purchased by
PDSP from Perkin-Elmer or GE Healthcare. Competition
binding assays were performed using transfected or stably
expressing cell membrane preparations as previously de-
scribed41,42 and all experimental details are available online
(http://pdsp.med.unc.edu/pdspw/binding.php).
■ RESULTS
QSAR Model Development to Classify 5-HT1A Actives
versus Inactives. Calculation of Descriptors. Dragon27
software (version 5.5) was used; initially, 880 chemically
relevant 0D-2D descriptors were calculated. A total of 672
descriptors were eventually used for 5-HT1A data set after
removing descriptors with zero value or zero variance.
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Furthermore, all descriptors were range-scaled to fall between
the values of zero and one.
kNN Classification. The kNN QSAR method with variable
selection afforded multiple models with optimal accuracy
characterized by CCR for both training and test sets. For the
five internal modeling sets (each one is comprised of
approximately 80% of the entire 5-HT1A data set) generated
after applying the external 5-fold cross-validation protocol (cf.
Table 1. QSAR Model Validations on the External 5-Fold CV Sets As Well As the Additional Independent External Set from
WOMBAT
confusion matrix statistics
machine learning methods external sets prediction CCR N(1)a N(2)a TP TN FP FN SE SP EN(1) EN(2)
1 0.86 19b 14 17 11 3 2 0.89 0.79 1.61 1.76
2 0.61 20 13 15 6 7 5 0.75 0.46 1.16 1.30
k-nearest neighbor 3 0.77 22 11 20 7 4 2 0.91 0.64 1.43 1.75
4 0.86 20 13 19 10 3 1 0.95 0.77 1.61 1.88
5 0.68 23 10 22 4 6 1 0.96 0.40 1.23 1.80
Cumulative 0.76 104 61 93 38 23 11 0.89 0.62 1.41 1.71
WOMBAT N/A 66 0 62 N/A N/A 4 0.94 N/A N/A N/A
1 0.80 20 14 16 11 3 4 0.80 0.79 1.58 1.59
2 0.68 20 13 15 8 5 5 0.75 0.62 1.32 1.42
random forest 3 0.84 22 11 21 8 3 1 0.95 0.73 1.56 1.88
4 0.74 20 13 19 7 6 1 0.95 0.54 1.35 1.83
5 0.83 23 10 22 7 3 1 0.96 0.70 1.52 1.88
Cumulative 0.78 105 61 93 41 20 12 0.89 0.67 1.46 1.71
WOMBAT N/A 66 0 62 N/A N/A 4 0.94 N/A N/A N/A
1 0.87 20 14 19 11 3 1 0.95 0.79 1.36 1.88
2 0.68 20 13 18 6 7 2 0.90 0.46 1.25 1.64
support vector machines 3 0.95 22 11 22 10 1 0 1.00 0.91 1.83 2.00
4 0.76 20 13 18 8 5 2 0.90 0.62 1.40 1.72
5 0.76 23 10 21 6 4 2 0.91 0.60 1.39 1.75
Cumulative 0.80 105 61 98 41 20 7 0.93 0.67 1.48 1.82
WOMBAT N/A 66 0 62 N/A N/A 4 0.96 N/A N/A N/A
aN(1) = number of actives, N(2) = number of inactives, TP = true positive (actives predicted as actives), FP = false positives (inactives predicted as
actives), FN = false negatives (actives predicted as inactives), TN = true negative (inactives predicted as inactives), SE = sensitivity = TP/N(1), SP =
specificity = TN/N(2), EN = the normalized enrichment, EN(1) = (2TP × N(2))/(TP × N(2) + FP × N(1)), EN(2) = (2TN × N(1))/(TN ×
N(1) + FN × N(2)), and CCR = correct classification rate. bSome N(1) actives of and N(2) inactives were out of application domain of all
consensus models, thus having no prediction. Only data for compounds found within the AD were used for statistical summaries.
Figure 2. Box plots for the external prediction accuracy (CCRevs) of different QSAR classification models for 5-HT1A actives. Lower horizontal line
of the box, 20th quantile; middle line, median; upper line, 80th quantile. Lower vertical line, range of data between 20th quantile and the minimum;
upper vertical line, range of data between the 80th quantile and the maximum. Square dot, mean.
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Table 2. Prediction Scores and Experimental Data for 15 Hits Identified by Virtual Screening As Putative 5-HT1A Actives
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Methods), there were a total of 838 models with both CCRtrain
and CCRtest equal to or higher than 0.80. Most models with
CCRtest ≥ 0.80 also had corresponding CCRtrain ≥ 0.80, but the
opposite was not always true. The high accuracy of the models
implied that these models could correctly identify the majority
of actives and inactives in both the training and test sets.
RF Classification. The RF QSAR classification method was
applied for the same five modeling sets used for kNN modeling.
For each modeling set, the decision trees were tuned and
selected under the RF algorithm and only the final model (a set
of classification trees) was reported (cf. Table 1). The external
5-fold cross-validation procedure (same as when using kNN)
was employed using the same division of the data set into five
folds; the resulting external accuracy ranged between 0.68 and
0.84 (cf. Table 1).
SVM Classification. The same five sets of modeling
compounds were also used to build SVM QSAR classification
models. Due to the limited number of models selected by using
0.80 as the cutoff for both CCRtrain and CCRtest, and the
potential unreliable predictions on external compounds by
using only few models, the models with both CCRtrain and
CCRtest ≥ 0.65 were considered acceptable and were selected
for consensus prediction; a total of 207 of such models were
retained.
QSAR Model Validations. In addition to the internal
validation of kNN, RF, and SVM models using test sets, Y-
randomization and external validation are the critical steps of
our QSAR workflow (Figure 1). Only models that have been
validated by these two steps can be employed for external
prediction and virtual screening.32 Furthermore, a data set of 66
5-HT1A actives from WOMBAT was used as the independent
external validation set.
Y-Randomization Test. The binary annotations of 5-HT1A
as actives or inactives in the training set were randomly
shuffled, and kNN, RF, and SVM classification models were
built with the same parameter settings as used in the original
data modeling. The Y-randomization test was performed once
for each training/test set split and all its runs showed that
almost all models had both CCRtrain and CCRtest around 0.50,
which is equivalent to random guess (cf. Figure 2). Because no
classification rules or hyperplanes can be identified by SVM
classification methods after the random shuffling of the original
5-HT1A annotations, no prediction could be further made for
the test set compounds, thus no statistics were reported in
Figure 2. Moreover, the one-tail hypothesis was applied, and a
Z score of 2.17 was calculated. After comparing this Z score
with the tabular critical values of Zc at different levels of
significance (α)60, we concluded that with 98.48% confidence
the null hypothesis H0 should be rejected, implying that the
difference of CCR for models built with the original data versus
those built with the data subjected to Y-randomization was
significant.
External Cross-Validation. The external 5-fold cross-
validation approach was employed for the external prediction,
i.e., for each split, models were built using ∼80% of the 5-HT1A
data set to predict the remaining randomly excluded ∼20% of
compounds. Consensus predictions were carried out using
models with both high CCRtrain and CCRtest. Exactly the same
external sets were employed for validation of kNN, RF, and
SVM classification models, and the results are compared and
Table 2. continued
aThe full IC50 curve was generated in further experiments and the Ki value was determined.
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summarized in both Figure 2 and Table 2. It is noticed that
only 19 out of 20 5-HT1A actives in the first external set were
predicted by kNN classification models; the remaining 5-HT1A
active compound could not be predicted by our consensus
kNN models because it was outside of the models’ applicability
domain. The consensus score, in terms of the average class
number in classification QSAR, was calculated by the fraction of
models that predicted a compound as inactive divided by the
total number of models used for prediction plus one; this
formula is based on the annotation of actives as having class
label of “1” and inactives as those with the class label of “2”.
Thus, if a set of classification QSAR models is used to predict a
compound’s activity, the mean predicted class could range
between 1 (when all models predict this compound as active)
and 2 (when all models predict this compound as inactive).
Obviously, when models disagree, the mean class label may take
any value between 1 and 2. Under n-cutoff = 0.5 (cf. eq 2),
most of the external validation set achieved a rather high
prediction accuracy. The highest accuracy for the kNN
classification models across all external validation folds was
observed for the fourth external set split (Table 1), with
sensitivity of 95% (for actives) and specificity of 77% (for
inactives), leading to CCRevs = 0.86. Increasing n-cutoff (eq 2)
raised the model coverage for predicting of both active and
inactive compounds because of the extended applicability
domain for individual models. However, the prediction with
extended applicability domain for consensus models also comes
with lower confidence level (data not shown). Generally
speaking, to have reliable predictions but also broad model
coverage, a reasonable n value should be selected.
The consensus scores for each of the compounds in the
external sets predicted by all three (kNN, RF, and SVM)
classification models are shown in Table 1. The models with
qualifying CCRtrain and CCRtest values in excess of 0.80 and the
highest CCRevs resulting for a single split of the data in the 5-
fold validation protocol were used in consensus for virtual
screening. Notably, the kNN models chosen for the prediction
had relatively small ncutoff (0.5) and relatively broad coverage
(≥50%) for compounds in external data sets.
Independent External Validation. We used models built for
a PDSP data set of 166 5-HT1A active/inactive compounds to
predict the class label for 66 known 5-HT1A actives from
WOMBAT. We should emphasize that these latter compounds
had unique structures that were different from the existing
PDSP actives. Among the 66 actives (all were within the
applicability domain), 62 were accurately annotated by kNN
consensus prediction (SE = 0.94, Table 1). Thus, the majority
of ligands were predicted correctly by our consensus models.
The only four incorrectly predicted compounds had the
consensus prediction scores of 1.51, 1.54, 1.55, and 1.67,
respectively. As illustrated above, consensus prediction is based
on the results obtained by all validated predictive models. The
closer the value is to 1.0, the greater the confidence in the
prediction of a compound being 5-HT1A active, whereas the
value closer to 2.0 implies greater confidence in predicting a
compound to be inactive. Because the predicted class labels for
the four false negative 5-HT1A actives did not exceed 1.67, and
compounds were within the applicability domain of only 70
models (i.e., approximately 30% of all models), the kNN
prediction is considered as of low confidence. When RF and
SVM were applied, the prediction accuracy for the additional 66
actives from WOMBAT was also high, ranging from CCRevs =
0.94 to 0.96 (Table 1).
The success of this independent external validation highlights
the power of our QSAR models in predicting the possible 5-
HT1A binding classifications, so that these models can be
reliably applied for virtual screening to identify novel 5-HT1A
receptor actives.
Figure 3. PCA plot of three types of virtual screening libraries along with the modeling set; the plots were generated from calculating the top three
principal components by using multiple chemical descriptors (Dragon 5.5, 0D-2D descriptors) of compound in respective libraries. Compounds
from the modeling set are colored in red; compounds from the Prestwick library are colored in green; compounds from the TimTec GPCR-targeted
library are colored in blue and compounds from the TimTec diversity library are colored in orange.
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Model-Based Virtual Screening. Models with the highest
predicted CCRevs for each machine learning method, i.e., 217
kNN models with both internal and external CCRtrain and
CCRtest equal to or greater than 0.80 and CCRevs equal to 0.86,
one RF model with CCRevs equal to 0.84, and 47 SVM models
with CCRevs equal to 0.95, were used in consensus for virtual
screening. Initially, 55 ,384 compounds from the Prestwick and
WDI libraries were screened to identify putative 5-HT1A
actives; the number of compounds falling within the AD
when the n-cutoff (cf. eq 2) was varied are shown in Figure 4. It
should be noted that there is a big overlap between compounds
screened by Prestwick and WDI libraries, and hits from WDI
also share the same or highly similar structures with
compounds in the modeling set. Therefore, only the screening
statistics from the Prestwick library are shown in Figure 4. The
compounds within the AD defined by n-cutoff = 0.5 were
further predicted by kNN consensus models. 234 compounds
from the Prestwick library were predicted as actives by at least
one of the kNN consensus models. To narrow the hit list and
obtain the higher confidence level for each prediction, we took
both the consensus score (average class number) and model
coverage into consideration; model coverage was defined as a
fraction of models for which a compound was found to fall
within the respective applicability domain. In particular, only
hits with an average class number between 1.0 and 1.1 and the
model coverage over 50% were selected. In total, 125
compounds from PCL and 181 from WDI were identified
that satisfied both criteria.
The majority of these virtual hits were found to be highly
similar to the compounds already known (compounds in the
QSAR modeling set), so it would be less interesting to test
these hits experimentally. To verify the diversity of those virtual
hits, pairwise similarity calculations were performed. Each
compound was represented by a fingerprint of 166 substructure
keys (MACCS structural keys43), indicating the presence or
absence of a particular chemical substructure. The pairwise
similarity was assessed by Tanimoto coefficients44 (Tc)
between PCL hits, between PCL hits and each hit’s nearest
neighbor from the actives in the modeling set (identified by the
lowest Euclidean distances calculated with the Dragon
descriptors), and between PCL hits and all actives in the
modeling set. The majority of compound pairs formed by
Prestwick’s virtual hits with each hit’s nearest neighbor within
the modeling set had Tc over 0.90, whereas other pairwise
similarity scores show a normal distribution, suggesting that the
virtual hits are structurally dissimilar from each other but highly
similar with known 5-HT1A actives (Figure 5). Furthermore,
the principal component analysis (PCA) was also conducted
and it could be easily seen that there is a big overlap between
the distribution of chemical space occupied by the Prestwick
library and modeling set compounds (Figure 3).
To explore more structurally diverse 5-HT1A compounds, we
further screened GPCR-targeted libraries and diversity libraries
from the commercial chemical sources of TimTec and
ASINEX. Thus, the additional collection of 24 000 compounds
was screened, which included the TimTec ActiTarg-G (GPCR-
targeted) library of about 2300 compounds, the ASINEX
Synergy GPCRs CNS (GPCR-targeted) library of about 7000
compounds, the TimTec Diversity Set 10K (diversity library)
of 10 000 compounds and the ASINEX Diversity Set-Platinum
5K (diversity library) of about 5100 compounds. The putative
hit rates for different screening libraries are shown in Figure 4
with various n-cutoff values (representing different applicability
domain), and the exact numbers of compounds chosen from
these libraries are also available in the Supporting Information
(Table S1). It is obvious that many more chemicals were
Figure 4. The hit rates of putative 5-HT1A actives identified in five different types of screening libraries by the global similarity search at three
different values of the applicability domain n-cutoff (−0.5; 0; +0.5).
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selected from the GPCR-targeted library than from the
diversity library by applying the same n value, verifying that
the diversity library has much more structural-varied com-
pounds than the GPCR-targeted library.
The binding potential for compounds within the AD of n =
0.5 was further predicted by kNN consensus models. 445
compounds from the TimTec ActiTarg-G library, 487 from the
TimTec Diversity Set 10K, 2177 from the ASINEX Synergy
GPCRs CNS library and 782 from the ASINEX Diversity Set-
Platinum 5K were predicted as actives by at least one of the
kNN consensus models. To narrow the hit list and obtain the
higher confidence level for each prediction, both the consensus
score and model coverage were taken into consideration. In
particular, only the hits with average class numbers between 1.0
and 1.1 and the model coverage over 50% were selected. We
found that there were 64 compounds from the TimTec
AntiTarg-G library and 40 from the TimTec Diversity Set 10K
that satisfied both criteria. As for ASINEX libraries, there were
still hundreds of compounds that met those strict criteria, but
we decided not to pursue these compounds at this time.
Several structural classes were observed by screening
different libraries according to the Tc values. Notably, many
of the 64 virtual hits from the TimTec AntiTarg-G library were
found to be structurally similar to actives used in model
building, whereas the 40 virtual hits from the TimTec Diversity
Set 10K had highly different structures. The pairwise similarity
measured by Tc values was also compared between virtual hits,
hits versus their nearest neighbor within the modeling set
compounds, virtual hits versus modeling set compounds, and
between modeling set compounds (Figure 5). It is clearly seen
that the virtual hits from the TimTec AntiTarg-G library had
chemical structures with a much lower similarity (Figure 5Ac)
to the known 5-HT1A actives than Prestwick virtual hits (Figure
5Bc). The average Tc value between TimTec Anti-Targ-G
library hits and their nearest neighbors in the modeling set was
0.60 compared to 0.90 for the hits screened from Prestwick. It
should be noted that the cutoff value for Tc to be defined as the
hits by major commercial packages for virtual screening is 0.80,
when combined with the 166 MACCS structural keys. For our
virtual hits screened from the TimTec Diversity Set 10K, the
Tc value between hits and their nearest neighbors in the
Figure 5. The distribution of the pairwise structural similarity within the sets of screening hits from three types of libraries in comparison to
modeling sets using the kernel density plot for Tc distribution: Aa, between hits from the Prestwick library; Ab, between the Prestwick hits and all
modeling set compounds; Ac, between the Prestwick hits and their nearest neighbors in the modeling set. Ba, Between TimTec GPCR-targeted
library hits; Bb, between the TimTec GPCR-targeted library hits and all modeling set compounds; Bc, between the GPCR-targeted library hits and
their nearest neighbors in the modeling set. Ca, Between TimTec diversity library hits; Cb, between the TimTec diversity library hits and all
modeling set compounds; Cc, between the TimTec diversity library hits and their nearest neighbors in the modeling set.
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modeling set was as low as around 0.45, suggesting that they are
highly structurally different. Although these hits are also
predicted to be 5-HT1A actives with a high confidence by our
consensus models as well as RF and SVM, it would be
interesting and exciting to test them experimentally, in a hope
of revealing 5-HT1A actives with a new scaffold. Moreover, the
visualization of the PCA plot also confirmed the broader
distribution in chemical space for compounds from the TimTec
diversity library compared with TimTec GPCR-targeted library
(cf. Figure 3).
From all virtual screening hits chosen by kNN, 15 chemicals
were further selected for the experimental testing, including five
compounds from PCL, five from TimTec AntiTarg-G library,
and five from TimTec Diversity Set 10K. The following
selection criteria were used: (1) high confidence of consensus
prediction by RF and SVM; (2) low structural similarity
between hits and the 5-HT1A actives we already known; (3)
commercial availability.
Experimental Validation. The validations of our in silico
hits by the NIMH PDSP yielded many actives that were
subsequently confirmed to have appreciable 5-HT1A binding
activity. We should stress that only binary QSAR models were
used for virtual screening so no prediction of exact binding
affinities (Ki values) could be made. Nine out of 15 in silico hits
were found to have the percent of inhibition equal to or higher
than 50% (i.e., Mesoridazine, Clozapine, Risperidone and
Fluphenazine from PCL; ST030580 from GPCR targeted
library; ST023860, ST074311, ST057540 and ST066677 from
the diversity library) and five of them displayed >95%
inhibition at 10 μM. For these more potent compounds, Ki
values were obtained (see Methods). The five in silico hits from
PCL showed the highest success rate (80%), though most of
them were similar to the modeling set compounds (Tc ranged
from 0.80 to 0.99, with an average Tc value of 0.86) and no
novel core scaffolds were found. They were also found to be
less interesting from the drug repurposing prospective.
Mesoridazine (Ki = 33.1 nM) and fluphenazine (Ki = 145.7
nM) belong to the typical antipsychotic class whereas clozapine
(Ki = 104.8 nM) and risperidone (Ki = 427.5 nM) are atypical
antipsychotics; all four drugs are commonly used in the
treatment of schizophrenia and bipolar disorder. The known
mechanism of action for mesoridazine as a phenothiazine
antipsychotic is through its potent binding with 5-HT2A and
dopamine receptors,45 whereas the binding with human 5-HT1A
receptors have not been reported before. The Ki of
fluphenazine,46 clozapine47 and risperidone48 for 5-HT1A have
been reported elsewhere; however, this data was not included
in PDSP and was unknown to us at the time of our
computational studies. Thus, these observations may be
considered as (re)discovery of the known mechanism of action
for known antipsychotics.
To our surprise, only one in silico hit from the GPCRs
targeted library was found to be active (Ki = 243.8 nM). This
compound, ST030580, showed a quite different ring arrange-
ment from its nearest neighbor compound in the modeling set,
while maintaining the azaspiro-bicyclic structural element.
Among the three confirmed hits from the TimTec Diversity
Set 10K, compound ST057540 (also known as Lysergol
([(8α)-6-methyl-9,10-didehydroergolin-8-yl]methanol))
yielded 98.20% binding inhibition against 5-HT1A receptor at
10 μM and its Ki value was found to be 2.3 nM afterward
(Figure 6). Furthermore, the Tc between this compound and
its nearest neighbor in the modeling set (ID: 27405, with
dibenzo[de,g]quinolone structure) is only 0.69, suggesting low
structural similarity between this molecule and any compound
in the modeling set. Lysergol is an alkaloid of the ergoline
family that occurs as a minor constituent in some species of
fungi. Lysergol is sometimes also utilized as an intermediate in
the manufacturing of some ergoloid medicines (e.g., nicergo-
line). This compound fully satisfies the “Lipinski’s Rule of
Five”,49 with a LogP value of 1.76, which is considered to be
ideal for both oral absorption and CNS penetration. It was also
predicted to have a very low probability of rapid biodegradation
by EPI-Suite.50 Literature search indicates that Lysergol binds
mainly to the GPCR targets and shows more selectivity toward
5-HT1 versus 5-HT2 receptors. Thus, our discovery that
Lysergol is a potent low nanomolar 5HT1A binder confounded
by its known high-affinity binding to 5-HT1B and 5-HT1D
51
suggests that Lysergol may find application in treating
schizophrenia as was suggested independently (e.g., by Groo
and Palosi).52 Two other active hits, compounds ST023860 and
ST074311, also feature relatively different scaffolds in
comparison to modeling set compounds with Tc of 0.75 and
0.69, respectively. In addition, one confirmed hit from the
Diversity Set, i.e. ST066677, showed the Tc as low as 0.53 to its
most similar compound. These compounds represent unique
scaffolds opening opportunities for the further investigation of
them as well as their close chemical analogs as novel
antipsychotic agents. In summary, the above results once
again prove the predictive power of our binary kNN, RF and
SVM classification QSAR models built from 5-HT1A actives/
inactives. These studies illustrate that QSAR models generated
by following the validated QSAR workflow, as employed in this
paper, could be used as a general tool for identifying promising
hits by the means of virtual screening of various types of
chemical libraries.
■ DISCUSSION
We should emphasize that rigorous model validation is an
inherent feature of our QSAR modeling workflow. This issue of
model validation has been given a lot of attention by the QSAR
research community.53 In the past, most practitioners merely
presumed that internally cross-validated models built from
available training set data should be externally predictive. We
and others have demonstrated that internal validation
techniques such as leave-one-out (LOO) or even leave-many-
out (LMO) cross-validation applied to the training set are
Figure 6. The full dose response curve for hit compounds ST057540
(arrow-up triangles, Ki = 2.3 nM), ST074311 (arrow-down triangles,
Ki = 8194 nM) and the positive control, Methysergide (solid squares,
Ki = 26 nM) measured by human 5-HT1A receptor radioligand binding
assay. The radioligand is [3H]-8-OH-DPAT at the concentration of 0.5
nM with the standard binding buffer.
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insufficient to ensure the external predictive power of QSAR
models.32,54 Thus, we used external 5-fold cross-validation
approach as well as the Y-randomization test in this study to
ensure the robustness and predictive power of our QSAR
models. Needless to say, the use of externally validated models
and applicability domains is especially critical when the models
are employed in virtual screening.
A set of unique 66 5-HT1A actives from different resources,
i.e., WOMBAT library, were further validated by our consensus
models. All three QSAR methods (kNN, RF and SVM) could
accurately annotate the majority of compounds, with CCRevs
ranged from 0.94 to 0.96. The success of this independent
external validation reassured us that our QSAR models were
indeed externally predictive, robust, and applicable to virtual
screening.
We have employed our QSAR models for virtual screening of
several chemical libraries, including two drug-like libraries, two
GPCR-targeted libraries and two diversity libraries. Both the
global similarity search (using AD) and the subsequent QSAR
model predictions confirmed our expectations that drug-like
libraries and GPCR-targeted libraries had a much higher
computational hit rate than diversity libraries when the same n-
cutoff values were applied. The screening hits from drug-like
libraries had much higher structural similarity to our modeling
set compounds than hits from GPCR-targeted or diversity
libraries. As described in Methods, 15 top hits (five best from
each of the diversity library, GPCR-targeted library, and drug-
like library) were chosen for the experimental validation and
nine out of these 15 compounds suggested by our QSAR
models were confirmed to be 5-HT1A actives. Interestingly,
overall the number of screening hits was higher for the GPCR-
targeted library than for the diversity library (cf. Figure 4) as
could be expected. However, the number of experimentally
confirmed hits was much higher for the diversity library (four
out five screening hits were validated experimentally; cf. Table
2) than that for the GPCR-targeted library (only one of five
screening hits was confirmed; cf. Table 2). Interestingly, the
most potent nanomolar 5-HT1A active compound (compound
No. 14 in Table 2; Ki = 2.3 nM) was identified from the
TimTec diversity library, sharing very low structural similarity
(Tc = 0.69) with its nearest neighbor compound in the
modeling set. These findings verified that model-based virtual
screening yielded hits that would not be detected using simple
similarity search because of their structural novelty as compared
to the training set compounds.
■ CONCLUSIONS
Our studies demonstrate that binary classification QSAR
models built with Dragon descriptors can accurately differ-
entiate true 5-HT1A actives from inactives. A state-of-the-art
QSAR modeling scheme was applied, and the models were
rigorously validated using both internal (multiple training/test
set divisions and Y-randomization) as well as external (5-fold
CV sets) validation approaches. We have demonstrated that
this strategy afforded multiple QSAR models with high internal
as well as external predictive power. The predictors were
further validated on the WOMBAT hits (66 literature extracted
compounds tested for 5-HT1A binding). We found that our
predictions agreed highly with the experimental annotation of
66 compounds as 5-HT1A actives as reported in various
publications. Furthermore, our models used in the most
conservative way, i.e., in consensus fashion and with the
strictest applicability domain criteria, identified 43 putative 5-
HT1A actives by mining three major types of screening libraries
including drug-like libraries (WDI and PCL), GPCR-targeted
libraries, and diversity libraries. Fifteen of them were tested
experimentally in the NIMH PDSP at UNC-Chapel Hill and
nine showed significant inhibition activities (≥50% inhibition)
in a single concentration. Interestingly, the five virtual hits
identified from the TimTec diversity library showed higher
success ratio (60% versus 20%) than the other five from the
TimTec GPCR-targeted library; slightly better results were also
reported for the PCL drug-like library (80%). One compound
(ST057540) was found to have the highest Ki of 2.3 nM among
all hits, whereas the Tc values between this compound and its
nearest neighbor in the modeling set (ID: 27405) was only
0.69. It was of great interest to find out that this compound,
Lysergol, though used as an intermediate in manufacturing of
some ergoloid medicines, had unclear pharmacological
indication, but many drug-like chemical properties suggesting
that we may have identified a yet unknown antischizophrenic
drug candidate. In summary, we have demonstrated that QSAR
models can be successfully used for finding promising and
structurally diverse hits by the means of virtual screening of
chemical libraries. All QSAR models developed and validated in
this study as virtual screening tools to identify 5HT1A ligands




The number of compounds chosen from all six screening
libraries by different ncutoff values, model predicted and
experiment tested data for 5-HT1A screening hits, chemical
structures for 5-HT1A modeling data set (actives and inactives)
and independent validation set, the Certificate of Analysis for
commercial compounds, as well as other supplementary data
indicated in the text. This material is available free of charge via
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